Daniel 2006.

Methods	Allocation: randomised. Blindness: not stated. Duration: 24‐hour IM phase followed by 4‐day oral phase.
Participants	Diagnosis: schizophrenia with agitation. N = 360. Age: range 18‐60 years. Sex: not stated. History: not stated. Exclusion: not stated. Setting: not stated.
Interventions	1. Haloperidol: dose 6.5 mg/IM, maximum 3 injections during 24 hours, followed by haloperidol 7 mg/p.o./day to 10 mg/p.o./day for 4 days. 2. Aripiprazole: dose 10 mg/IM, maximum 3 injections during 24 hours, followed by haloperidol 10 mg/p.o./day to 15 mg/p.o./day for 4 days.
Outcomes	Global state: CGI‐I, CGI‐S. Agitation: PANSS‐EC, ACES, CABS.
Notes	Conference proceeding, full characteristics and outcome data not reported. Additionally, unclear whether this is the same study as Bristol‐Myers 2005b ‐ attempted to contact Bristol Myers.